Corteva annual r&d spending
2018
2019
2020
2021
2022
2023
2024
2025
Corteva R&D Spending Growth & History (CTVA)
Corteva's r&d spending was $1.47B for fiscal 2025.
View full Corteva company overviewCorteva annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.47B | $72.0M | +5.14% |
| 2024 | 2024-12-31 | $1.40B | $65.0M | +4.86% |
| 2023 | 2023-12-31 | $1.34B | $121.0M | +9.95% |
| 2022 | 2022-12-31 | $1.22B | $29.0M | +2.44% |
| 2021 | 2021-12-31 | $1.19B | $45.0M | +3.94% |
| 2020 | 2020-12-31 | $1.14B | −$5.0M | −0.44% |
| 2019 | 2019-12-31 | $1.15B | −$208.0M | −15.35% |
| 2018 | 2018-12-31 | $1.35B | — | — |
Corteva quarterly r&d spending
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $388.0M | $13.0M | +3.47% |
| Q1 2026 | 2026-03-31 | $341.0M | $6.0M | +1.79% |
| Q4 2025 | 2025-12-31 | $413.0M | $48.0M | +13.15% |
| Q3 2025 | 2025-09-30 | $351.0M | $3.0M | +0.86% |
| Q2 2025 | 2025-06-30 | $375.0M | $18.0M | +5.04% |
| Q1 2025 | 2025-03-31 | $335.0M | $3.0M | +0.90% |
| Q4 2024 | 2024-12-31 | $365.0M | $8.0M | +2.24% |
| Q3 2024 | 2024-09-30 | $348.0M | $13.0M | +3.88% |
| Q2 2024 | 2024-06-30 | $357.0M | $28.0M | +8.51% |
| Q1 2024 | 2024-03-31 | $332.0M | $16.0M | +5.06% |
| Q4 2023 | 2023-12-31 | $357.0M | $17.0M | +5.00% |
| Q3 2023 | 2023-09-30 | $335.0M | $23.0M | +7.37% |
| Q2 2023 | 2023-06-30 | $329.0M | $33.0M | +11.15% |
| Q1 2023 | 2023-03-31 | $316.0M | $48.0M | +17.91% |
| Q4 2022 | 2022-12-31 | $340.0M | $24.0M | +7.59% |
| Q3 2022 | 2022-09-30 | $312.0M | $15.0M | +5.05% |
| Q2 2022 | 2022-06-30 | $296.0M | $3.0M | +1.02% |
| Q1 2022 | 2022-03-31 | $268.0M | −$13.0M | −4.63% |
| Q4 2021 | 2021-12-31 | $316.0M | $11.0M | +3.61% |
| Q3 2021 | 2021-09-30 | $297.0M | $13.0M | +4.58% |
| Q2 2021 | 2021-06-30 | $293.0M | $20.0M | +7.33% |
| Q1 2021 | 2021-03-31 | $281.0M | $1.0M | +0.36% |
| Q4 2020 | 2020-12-31 | $305.0M | $15.0M | +5.17% |
| Q3 2020 | 2020-09-30 | $284.0M | −$5.0M | −1.73% |
| Q2 2020 | 2020-06-30 | $273.0M | $4.0M | +1.49% |
| Q1 2020 | 2020-03-31 | $280.0M | −$19.0M | −6.35% |
| Q4 2019 | 2019-12-31 | $290.0M | −$4.0M | −1.36% |
| Q3 2019 | 2019-09-30 | $289.0M | −$36.0M | −11.08% |
| Q2 2019 | 2019-06-30 | $269.0M | −$85.0M | −24.01% |
| Q1 2019 | 2019-03-31 | $299.0M | −$83.0M | −21.73% |
| Q4 2018 | 2018-12-31 | $294.0M | — | — |
| Q3 2018 | 2018-09-30 | $325.0M | — | — |
| Q2 2018 | 2018-06-30 | $354.0M | — | — |
| Q1 2018 | 2018-03-31 | $382.0M | — | — |
Corteva r&d spending trends
Over the last five fiscal years, Corteva's r&d spending increased from $1.14B to $1.47B, a change of $332.0M. The latest reported quarter, Q2 2026, shows $388.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Corteva source filings ↗Community posts
Corteva settles Inari seed-IP case, with licensing talks still pending
Corteva ($CTVA) and Inari have reached a confidential settlement of Corteva’s seed-related intellectual-property lawsuit in Delaware. Inari agreed to destroy Corteva material accessed through seed depositories, together with material develo ...
Corteva clears SEC registration milestone for Vylor separation
Corteva ($CTVA) said the SEC declared Vylor’s Form 10 registration statement effective, advancing the planned separation of its seed and genetics business. Eligible Corteva shareholders are scheduled to receive one Vylor share for each Cort ...
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...
